A5—A dual-target antiviral compound that rewrites the rules of influenza therapy
Saved in:
| Main Author: | Shibo Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525005118 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repurposing FDA-approved drugs and natural compounds to inhibit the RNA-dependent RNA polymerase domain of dengue virus 2 or dengue virus 3
by: Khadijeh Ahmadi, et al.
Published: (2025-04-01) -
Bioprospection for antiviral compounds from selected medicinal plants against RNA polymerase of rotavirus A using molecular modelling and density functional theory
by: Adedayo Ayodeji Lanrewaju, et al.
Published: (2024-12-01) -
Research Note: Establishment of vector system harboring duck RNA polymerase I promoter for avian influenza virus
by: Yunyueng Jang, et al.
Published: (2025-01-01) -
Exploring Echinacea angustifolia for anti-viral compounds against Zika virus RNA-dependent RNA polymerase: a computational study
by: Mai M. El-Daly, et al.
Published: (2025-02-01) -
Identification of Benzothiophene-Derived Inhibitors of Flaviviruses by Targeting RNA-Dependent RNA Polymerase
by: Leah Liu Wang, et al.
Published: (2025-01-01)